Immunoassay Market is expected to grow at a CAGR of 6.50% during the forecast period. Global Immunoassay Market is expected to reach US$ 47.11 Bn. by 2029.Immunoassay Market Introduction and Overview:
Immunoassays are bio analytical methods in which the quantitation of the analyte depends on the reaction of an antigen and an antibody. Immunoassays have been widely used in many important areas of pharmaceutical analysis such as diagnosis of diseases, therapeutic drug monitoring, clinical pharmacokinetics and bioequivalence studies in drug discovery and pharmaceutical industries. The importance and widespread of immunoassay methods in the pharmaceutical analysis are attributed to their inherent specificity, high-throughput, and high sensitivity for the analysis of the wide range of analytes in biological samples. Recent improvements are achieved in the field of immunoassay development for the purposes of pharmaceutical analysis.To know about the Research Methodology :- Request Free Sample Report The prevalence and incidence of cancer cases are dramatically increasing globally, thus the application of immunoassay for early diagnosis and monitoring of cancer is growing gradually. According to American Cancer Society, lung cancer is one of the most common forms of cancer. In 2022, nearly 2.09 million people across the globe were living with lung cancer, and according to the WHO, this number is increase by 2.27 million in 2022. Immunoassays have been one of the fast-growing clinical diagnostics technologies over the years. The technological advancements in immunoassays driven by the need for early detection of diseases have supported their adoption over the years, and hence have supported the immunoassay market growth.Important advances have been made in the design of immunochemical approaches that allow small molecules, such as drugs, metabolites, and toxins, to substitute dynamic format assays with non-competitive formats, bringing advantages are previously seen only with large molecular analytes. The report has profiled fifteen key players in the market from different regions. However, report has considered all market leaders, followers and new entrants with investors while analysing the market and estimation the size of the same. The growing healthcare infrastructure in each region is different and focus is given on availability of advanced technology and new techniques The report contains detailed analysis of Strengths, Weakness and opportunities of the key players operating in the Immunoassy Market. It also provides information on current market trends, competitive ranking analysis, regional bifurcation, turnover forecasts, industry drivers and the key challenges.
Immunoassay Market Segment Analysis
Radioimmunoassays have wide applications in cancer detection, blood screening for hepatitis, diagnosis of ulcers, and narcotics detection. These assays are capable of the quantification of very small concentrations of antigens from small volumes of samples with the help of radioisotopes, such as iodine-125 and iodine-131. The growth in this immunoassay market is primarily driven by the increasing prevalence of cancer across the globe and the resultant increase in suitable diagnostic technologies. However, these assays are relatively high-cost assays and have potential health hazards owing to the use of radioactive antigens. This, along with additional expenses towards maintaining radiation safety and disposal protocols limit their wide-scale use. Owing to these, radioimmunoassay is increasingly being replaced by EIAs and CLIAs, which is expected to hamper the growth of the radioimmunoassay market over the coming years. Endocrine disorders have shown significant growth in recent years. Healthcare providers have started using immunoassay machines for the same. The endocrinology segment is expected to grow at a CAGR of 6.5% by 2029. Endocrinology tests have a wide range of applications, which include immunoassay analyzer testing, anti-TSH receptors testing, fertility testing, and women’s health testing. Such widespread applications are helping the segment expand at a faster pace, thereby growing the market.Regional Analysis
The immunoassay market of North America is expected to dominate the market accounting for nearly 40% of the total market share and registering a CAGR of 6.0% in the forecast period. Growing mergers & acquisitions are observed among in-vitro diagnostic and life sciences players in North America. This is anticipated to largely propel the region’s growth in the future. Key market players are strengthening their product portfolio by venturing into various medical specialty domains. Asia-Pacific is expected to emerge as the fastest-growing region, at a CAGR of 7.0% in the forecast period. This growth is attributed to the high prevalence and incidence rate of chronic and infectious diseases, which has increased per capita healthcare expenditure. Additionally, intensifying competition among diagnostic laboratories and hospitals and subsequent differentiation of products is expected to leverage demand for high-quality immunoassay analyzers, reagents and kits in the Asia-Pacific market.Immunoassay Market Scope : Inquire before Buying
Global Immunoassay Market Report Coverage Details Base Year: 2022 Forecast Period: 2023-2029 Historical Data: 2018 to 2022 Market Size in 2022: US$ 30.31 Bn. Forecast Period 2023 to 2029 CAGR: 6.50% Market Size in 2029: US$ 47.11 Bn. Segments Covered: by Technology Radioimmunoassay (RIA) Enzyme Immunoassay (EIA) Rapid test Others by Product Reagents & kits Analyzers/instruments Software & services by Application Therapeutic drug monitoring Oncology Cardiology Endocrinology Immunoassay Market ,by Region
Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC) Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe) North America (United States, Canada and Mexico) Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A) South America (Brazil, Argentina Rest of South America)Key players
1. Siemens Healthineers 2. Becton 3. Dickinson & Company 4. BioMérieux 5. Abbott laboratories 6. Roche Diagnostics 7. Danaher Corporation 8. Ortho Clinical Diagnostics 9. Sysmex Corporation 10. Thermo Fisher Scientific, Inc. 11. Quidel Corporation 12. Agilent Technologies 13. PerkinElmer 14. Mindray 15. DiaSorin Frequently Asked Questions: 1. Which region has the largest share in Global Immunoassay Market? Ans: North America region holds the highest share in 2022. 2. What is the growth rate of Global Immunoassay Market? Ans: The Global Immunoassay Market is growing at a CAGR of 6.50% during forecasting period 2023-2029. 3. What is scope of the Global Immunoassay market report? Ans: Global Immunoassay Market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period. 4. Who are the key players in Global Immunoassay market? Ans: The important key players in the Global Immunoassay Market are – Siemens Healthineers, Becton, Dickinson & Company, BioMérieux, Abbott laboratories, Roche Diagnostics, Danaher Corporation, Ortho Clinical Diagnostics, Sysmex Corporation, Thermo Fisher Scientific, Inc., Quidel Corporation, Agilent Technologies, PerkinElmer, Mindray, and DiaSorin. 5. What is the study period of this market? Ans: The Global Immunoassay Market is studied from 2022 to 2029.
Global Immunoassay Market
1. Preface 1.1. Report Scope and Market Segmentation 1.2. Research Highlights 1.3. Research Objectives 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Sources 2.3.2. Primary Research 2.3.2.1. Data from Primary Sources 2.3.2.2. Breakdown of Primary Sources 3. Executive Summary: Market Size, By Market Value (US$ Mn) 4. Market Overview 4.1. Introduction 4.2. Market Indicator 4.2.1. Drivers 4.2.2. Restraints 4.2.3. Opportunities 4.2.4. Challenges 4.3. Porter’s Analysis 4.4. Value Chain Analysis 4.5. Market Risk Analysis 4.6. SWOT Analysis 4.7. Industry Trends and Emerging Technologies 5. Supply Side and Demand Side Indicators 6. Global Immunoassay Market Analysis and Forecast 6.1. Market Size & Y-o-Y Growth Analysis 6.1.1. North America 6.1.2. Europe 6.1.3. Asia Pacific 6.1.4. Middle East & Africa 6.1.5. South America 7. Global Immunoassay Market Analysis and Forecast, By Technology 7.1. Introduction and Definition 7.2. Key Findings 7.3. Market Value Share Analysis, By Technology 7.4. Market Size (US$ Mn) Forecast, By Technology 7.5. Market Analysis, By Technology 7.6. Market Attractiveness Analysis, By Technology 8. Global Immunoassay Market Analysis and Forecast, By Product 8.1. Introduction and Definition 8.2. Key Findings 8.3. Market Value Share Analysis, By Product 8.4. Market Size (US$ Mn) Forecast, By Product 8.5. Market Analysis, By Product 8.6. Market Attractiveness Analysis, By Product 9. Global Immunoassay Market Analysis and Forecast By Application 9.1. Introduction and Definition 9.2. Key Findings 9.3. Market Value Share Analysis, By Application 9.4. Market Size (US$ Mn) Forecast, By Application 9.5. Market Analysis, By Application 9.6. Market Attractiveness Analysis, By Application 10. Global Immunoassay Market Analysis, By Region 10.1. Market Value Share Analysis, By Region 10.2. Market Size (US$ Mn) Forecast, By Region 10.3. Market Attractiveness Analysis, By Region 11. North America Immunoassay Market Analysis 11.1. Key Findings 11.2. North America Market Overview 11.3. North America Market Value Share Analysis, By Technology 11.4. North America Market Forecast, By Technology 11.4.1. Radioimmunoassay (RIA) 11.4.2. Enzyme Immunoassay (EIA) 11.4.3. Rapid test 11.4.4. Others 11.5. North America Market Value Share Analysis, By Product 11.6. North America Market Forecast, By Product 11.6.1. Reagents & kits 11.6.2. Analyzers/instruments 11.6.3. Software & services 11.7. North America Market Value Share Analysis, By Application 11.8. North America Market Forecast, By Application 11.8.1. Therapeutic drug monitoring 11.8.2. Oncology 11.8.3. Cardiology 11.8.4. Endocrinology 11.9. North America Market Value Share Analysis, By Country 11.10. North America Market Forecast, By Country 11.10.1. U.S. 11.10.2. Canada 11.10.3. Mexico 11.11. North America Market Analysis, By Country 11.12. U.S. Market Forecast, By Technology 11.12.1. Radioimmunoassay (RIA) 11.12.2. Enzyme Immunoassay (EIA) 11.12.3. Rapid test 11.12.4. Others 11.13. U.S. Market Forecast, By Product 11.13.1. Reagents & kits 11.13.2. Analyzers/instruments 11.13.3. Software & services 11.14. U.S. Market Forecast, By Application 11.14.1. Therapeutic drug monitoring 11.14.2. Oncology 11.14.3. Cardiology 11.14.4. Endocrinology 11.15. Canada Market Forecast, By Technology 11.15.1. Radioimmunoassay (RIA) 11.15.2. Enzyme Immunoassay (EIA) 11.15.3. Rapid test 11.15.4. Others 11.16. Canada Market Forecast, By Product 11.16.1. Reagents & kits 11.16.2. Analyzers/instruments 11.16.3. Software & services 11.17. Canada Market Forecast, By Application 11.17.1. Therapeutic drug monitoring 11.17.2. Oncology 11.17.3. Cardiology 11.17.4. Endocrinology 11.18. Mexico Market Forecast, By Technology 11.18.1. Radioimmunoassay (RIA) 11.18.2. Enzyme Immunoassay (EIA) 11.18.3. Rapid test 11.18.4. Others 11.19. Mexico Market Forecast, By Product 11.19.1. Reagents & kits 11.19.2. Analyzers/instruments 11.19.3. Software & services 11.20. Mexico Market Forecast, By Application 11.20.1. Therapeutic drug monitoring 11.20.2. Oncology 11.20.3. Cardiology 11.20.4. Endocrinology 11.21. North America Market Attractiveness Analysis 11.21.1. By Technology 11.21.2. By Product 11.21.3. By Application 11.22. PEST Analysis 11.23. Key Trends 11.24. Key Developments 12. Europe Immunoassay Market Analysis 12.1. Key Findings 12.2. Europe Market Overview 12.3. Europe Market Value Share Analysis, By Technology 12.4. Europe Market Forecast, By Technology 12.4.1. Radioimmunoassay (RIA) 12.4.2. Enzyme Immunoassay (EIA) 12.4.3. Rapid test 12.4.4. Others 12.5. Europe Market Value Share Analysis, By Product 12.6. Europe Market Forecast, By Product 12.6.1. Reagents & kits 12.6.2. Analyzers/instruments 12.6.3. Software & services 12.7. Europe Market Value Share Analysis, By Application 12.8. Europe Market Forecast, By Application 12.8.1. Therapeutic drug monitoring 12.8.2. Oncology 12.8.3. Cardiology 12.8.4. Endocrinology 12.9. Europe Market Value Share Analysis, By Country 12.10. Europe Market Forecast, By Country 12.10.1. Germany 12.10.2. U.K. 12.10.3. France 12.10.4. Italy 12.10.5. Spain 12.10.6. Sweden 12.10.7. CIS countries 12.10.8. Rest of Europe 12.11. Germany Market Forecast, By Technology 12.11.1. Radioimmunoassay (RIA) 12.11.2. Enzyme Immunoassay (EIA) 12.11.3. Rapid test 12.11.4. Others 12.12. Germany Market Forecast, By Product 12.12.1. Reagents & kits 12.12.2. Analyzers/instruments 12.12.3. Software & services 12.13. Germany Market Forecast, By Application 12.13.1. Therapeutic drug monitoring 12.13.2. Oncology 12.13.3. Cardiology 12.13.4. Endocrinology 12.14. U.K. Market Forecast, By Technology 12.14.1. Radioimmunoassay (RIA) 12.14.2. Enzyme Immunoassay (EIA) 12.14.3. Rapid test 12.14.4. Others 12.15. U.K. Market Forecast, By Product 12.15.1. Reagents & kits 12.15.2. Analyzers/instruments 12.15.3. Software & services 12.16. U.K. Market Forecast, By Application 12.16.1. Therapeutic drug monitoring 12.16.2. Oncology 12.16.3. Cardiology 12.16.4. Endocrinology 12.17. France Market Forecast, By Technology 12.17.1. Radioimmunoassay (RIA) 12.17.2. Enzyme Immunoassay (EIA) 12.17.3. Rapid test 12.17.4. Others 12.18. France Market Forecast, By Product 12.18.1. Reagents & kits 12.18.2. Analyzers/instruments 12.18.3. Software & services 12.19. France Market Forecast, By Application 12.19.1. Therapeutic drug monitoring 12.19.2. Oncology 12.19.3. Cardiology 12.19.4. Endocrinology 12.20. Italy Market Forecast, By Technology 12.20.1. Radioimmunoassay (RIA) 12.20.2. Enzyme Immunoassay (EIA) 12.20.3. Rapid test 12.20.4. Others 12.21. Italy Market Forecast, By Product 12.21.1. Reagents & kits 12.21.2. Analyzers/instruments 12.21.3. Software & services 12.22. Italy Market Forecast, By Application 12.22.1. Therapeutic drug monitoring 12.22.2. Oncology 12.22.3. Cardiology 12.22.4. Endocrinology 12.23. Spain Market Forecast, By Technology 12.23.1. Radioimmunoassay (RIA) 12.23.2. Enzyme Immunoassay (EIA) 12.23.3. Rapid test 12.23.4. Others 12.24. Spain Market Forecast, By Product 12.24.1. Reagents & kits 12.24.2. Analyzers/instruments 12.24.3. Software & services 12.25. Spain Market Forecast, By Application 12.25.1. Therapeutic drug monitoring 12.25.2. Oncology 12.25.3. Cardiology 12.25.4. Endocrinology 12.26. Sweden Market Forecast, By Technology 12.26.1. Radioimmunoassay (RIA) 12.26.2. Enzyme Immunoassay (EIA) 12.26.3. Rapid test 12.26.4. Others 12.27. Sweden Market Forecast, By Product 12.27.1. Reagents & kits 12.27.2. Analyzers/instruments 12.27.3. Software & services 12.28. Sweden Market Forecast, By Application 12.28.1. Therapeutic drug monitoring 12.28.2. Oncology 12.28.3. Cardiology 12.28.4. Endocrinology 12.29. CIS countries Market Forecast, By Technology 12.29.1. Radioimmunoassay (RIA) 12.29.2. Enzyme Immunoassay (EIA) 12.29.3. Rapid test 12.29.4. Others 12.30. CIS countries Market Forecast, By Product 12.30.1. Reagents & kits 12.30.2. Analyzers/instruments 12.30.3. Software & services 12.31. CIS countries Market Forecast, By Application 12.31.1. Therapeutic drug monitoring 12.31.2. Oncology 12.31.3. Cardiology 12.31.4. Endocrinology 12.32. Rest of Europe Market Forecast, By Technology 12.32.1. Radioimmunoassay (RIA) 12.32.2. Enzyme Immunoassay (EIA) 12.32.3. Rapid test 12.32.4. Others 12.33. Rest of Europe Market Forecast, By Product 12.33.1. Reagents & kits 12.33.2. Analyzers/instruments 12.33.3. Software & services 12.34. Rest of Europe Market Forecast, By Application 12.34.1. Therapeutic drug monitoring 12.34.2. Oncology 12.34.3. Cardiology 12.34.4. Endocrinology 12.35. Europe Market Attractiveness Analysis 12.35.1. By Product 12.35.2. By Technology 12.35.3. By Application 12.36. PEST Analysis 12.37. Key Trends 12.38. Key Developments 13. Asia Pacific Immunoassay Market Analysis 13.1. Key Findings 13.2. Asia Pacific Market Overview 13.3. Asia Pacific Market Value Share Analysis, By Technology 13.4. Asia Pacific Market Forecast, By Technology 13.4.1. Radioimmunoassay (RIA) 13.4.2. Enzyme Immunoassay (EIA) 13.4.3. Rapid test 13.4.4. Others 13.5. Asia Pacific Market Value Share Analysis, By Product 13.6. Asia Pacific Market Forecast, By Product 13.6.1. Reagents & kits 13.6.2. Analyzers/instruments 13.6.3. Software & services 13.7. Asia Pacific Market Value Share Analysis, By Application 13.8. Asia Pacific Market Forecast, By Application 13.8.1. Therapeutic drug monitoring 13.8.2. Oncology 13.8.3. Cardiology 13.8.4. Endocrinology 13.9. Asia Pacific Market Value Share Analysis, By Country 13.10. Asia Pacific Market Forecast, By Country 13.10.1. China 13.10.2. India 13.10.3. Japan 13.10.4. South Korea 13.10.5. Australia 13.10.6. ASEAN 13.10.7. Rest of Asia Pacific 13.11. Asia Pacific Market Analysis, By Country 13.12. China Market Forecast, By Technology 13.12.1. Radioimmunoassay (RIA) 13.12.2. Enzyme Immunoassay (EIA) 13.12.3. Rapid test 13.12.4. Others 13.13. China Market Forecast, By Product 13.13.1. Reagents & kits 13.13.2. Analyzers/instruments 13.13.3. Software & services 13.14. China Market Forecast, By Application 13.14.1. Therapeutic drug monitoring 13.14.2. Oncology 13.14.3. Cardiology 13.14.4. Endocrinology 13.15. India Market Forecast, By Technology 13.15.1. Radioimmunoassay (RIA) 13.15.2. Enzyme Immunoassay (EIA) 13.15.3. Rapid test 13.15.4. Others 13.16. India Market Forecast, By Product 13.16.1. Reagents & kits 13.16.2. Analyzers/instruments 13.16.3. Software & services 13.17. India Market Forecast, By Application 13.17.1. Therapeutic drug monitoring 13.17.2. Oncology 13.17.3. Cardiology 13.17.4. Endocrinology 13.18. Japan Market Forecast, By Technology 13.18.1. Radioimmunoassay (RIA) 13.18.2. Enzyme Immunoassay (EIA) 13.18.3. Rapid test 13.18.4. Others 13.19. Japan Market Forecast, By Product 13.19.1. Reagents & kits 13.19.2. Analyzers/instruments 13.19.3. Software & services 13.20. Japan Market Forecast, By Application 13.20.1. Therapeutic drug monitoring 13.20.2. Oncology 13.20.3. Cardiology 13.20.4. Endocrinology 13.21. South Korea Market Forecast, By Technology 13.21.1. Radioimmunoassay (RIA) 13.21.2. Enzyme Immunoassay (EIA) 13.21.3. Rapid test 13.21.4. Others 13.22. South Korea Market Forecast, By Product 13.22.1. Reagents & kits 13.22.2. Analyzers/instruments 13.22.3. Software & services 13.23. South Korea Market Forecast, By Application 13.23.1. Therapeutic drug monitoring 13.23.2. Oncology 13.23.3. Cardiology 13.23.4. Endocrinology 13.24. Australia Market Forecast, By Technology 13.24.1. Radioimmunoassay (RIA) 13.24.2. Enzyme Immunoassay (EIA) 13.24.3. Rapid test 13.24.4. Others 13.25. Australia Market Forecast, By Product 13.25.1. Reagents & kits 13.25.2. Analyzers/instruments 13.25.3. Software & services 13.26. Australia Market Forecast, By Application 13.26.1. Therapeutic drug monitoring 13.26.2. Oncology 13.26.3. Cardiology 13.26.4. Endocrinology 13.27. ASEAN Market Forecast, By Technology 13.27.1. Radioimmunoassay (RIA) 13.27.2. Enzyme Immunoassay (EIA) 13.27.3. Rapid test 13.27.4. Others 13.28. ASEAN Market Forecast, By Product 13.28.1. Reagents & kits 13.28.2. Analyzers/instruments 13.28.3. Software & services 13.29. ASEAN Market Forecast, By Application 13.29.1. Therapeutic drug monitoring 13.29.2. Oncology 13.29.3. Cardiology 13.29.4. Endocrinology 13.30. Rest of Asia Pacific Market Forecast, By Technology 13.30.1. Radioimmunoassay (RIA) 13.30.2. Enzyme Immunoassay (EIA) 13.30.3. Rapid test 13.30.4. Others 13.31. Rest of Asia Pacific Market Forecast, By Product 13.31.1. Reagents & kits 13.31.2. Analyzers/instruments 13.31.3. Software & services 13.32. Rest of Asia Pacific Market Forecast, By Application 13.32.1. Therapeutic drug monitoring 13.32.2. Oncology 13.32.3. Cardiology 13.32.4. Endocrinology 13.33. Asia Pacific Market Attractiveness Analysis 13.33.1. By Technology 13.33.2. By Product 13.33.3. By Application 13.34. PEST Analysis 13.35. Key Trends 13.36. Key Developments 14. Middle East & Africa Immunoassay Market Analysis 14.1. Key Findings 14.2. Middle East & Africa Market Overview 14.3. Middle East & Africa Market Value Share Analysis, By Technology 14.4. Middle East & Africa Market Forecast, By Technology 14.4.1. Radioimmunoassay (RIA) 14.4.2. Enzyme Immunoassay (EIA) 14.4.3. Rapid test 14.4.4. Others 14.5. Middle East & Africa Market Value Share Analysis, By Product 14.6. Middle East & Africa Market Forecast, By Product 14.6.1. Reagents & kits 14.6.2. Analyzers/instruments 14.6.3. Software & services 14.7. Middle East & Africa Market Value Share Analysis, By Application 14.8. Middle East & Africa Market Forecast, By Application 14.8.1. Therapeutic drug monitoring 14.8.2. Oncology 14.8.3. Cardiology 14.8.4. Endocrinology 14.9. Middle East & Africa Market Value Share Analysis, By Country 14.10. Middle East & Africa Market Forecast, By Country 14.10.1. GCC Countries 14.10.2. South Africa 14.10.3. Nigeria 14.10.4. Egypt 14.10.5. Rest of Middle East & Africa 14.11. Middle East & Africa Market Analysis, By Country 14.12. GCC Countries Market Forecast, By Technology 14.12.1. Radioimmunoassay (RIA) 14.12.2. Enzyme Immunoassay (EIA) 14.12.3. Rapid test 14.12.4. Others 14.13. GCC Countries Market Forecast, By Product 14.13.1. Reagents & kits 14.13.2. Analyzers/instruments 14.13.3. Software & services 14.14. GCC Countries Market Forecast, By Application 14.14.1. Therapeutic drug monitoring 14.14.2. Oncology 14.14.3. Cardiology 14.14.4. Endocrinology 14.15. South Africa Market Forecast, By Technology 14.15.1. Radioimmunoassay (RIA) 14.15.2. Enzyme Immunoassay (EIA) 14.15.3. Rapid test 14.15.4. Others 14.16. South Africa Market Forecast, By Product 14.16.1. Reagents & kits 14.16.2. Analyzers/instruments 14.16.3. Software & services 14.17. South Africa Market Forecast, By Application 14.17.1. Therapeutic drug monitoring 14.17.2. Oncology 14.17.3. Cardiology 14.17.4. Endocrinology 14.18. Nigeria Market Forecast, By Technology 14.18.1. Radioimmunoassay (RIA) 14.18.2. Enzyme Immunoassay (EIA) 14.18.3. Rapid test 14.18.4. Others 14.19. Nigeria Market Forecast, By Product 14.19.1. Reagents & kits 14.19.2. Analyzers/instruments 14.19.3. Software & services 14.20. Nigeria Market Forecast, By Application 14.20.1. Therapeutic drug monitoring 14.20.2. Oncology 14.20.3. Cardiology 14.20.4. Endocrinology 14.21. Egypt Market Forecast, By Technology 14.21.1. Radioimmunoassay (RIA) 14.21.2. Enzyme Immunoassay (EIA) 14.21.3. Rapid test 14.21.4. Others 14.22. Egypt Market Forecast, By Product 14.22.1. Reagents & kits 14.22.2. Analyzers/instruments 14.22.3. Software & services 14.23. Egypt Market Forecast, By Application 14.23.1. Therapeutic drug monitoring 14.23.2. Oncology 14.23.3. Cardiology 14.23.4. Endocrinology 14.24. Rest of Middle East & Africa Market Forecast, By Technology 14.24.1. Radioimmunoassay (RIA) 14.24.2. Enzyme Immunoassay (EIA) 14.24.3. Rapid test 14.24.4. Others 14.25. Rest of Middle East & Africa Market Forecast, By Product 14.25.1. Reagents & kits 14.25.2. Analyzers/instruments 14.25.3. Software & services 14.26. Rest of Middle East & Africa Market Forecast, By Application 14.26.1. Therapeutic drug monitoring 14.26.2. Oncology 14.26.3. Cardiology 14.26.4. Endocrinology 14.27. Middle East & Africa Market Attractiveness Analysis 14.27.1. By Technology 14.27.2. By Product 14.27.3. By Application 14.28. PEST Analysis 14.29. Key Trends 14.30. Key Developments 15. South America Immunoassay Market Analysis 15.1. Key Findings 15.2. South America Market Overview 15.3. South America Market Value Share Analysis, By Technology 15.4. South America Market Forecast, By Technology 15.4.1. Radioimmunoassay (RIA) 15.4.2. Enzyme Immunoassay (EIA) 15.4.3. Rapid test 15.4.4. Others 15.5. South America Market Value Share Analysis, By Product 15.6. South America Market Forecast, By Product 15.6.1. Reagents & kits 15.6.2. Analyzers/instruments 15.6.3. Software & services 15.7. South America Market Value Share Analysis, By Application 15.8. South America Market Forecast, By Application 15.8.1. Therapeutic drug monitoring 15.8.2. Oncology 15.8.3. Cardiology 15.8.4. Endocrinology 15.9. South America Market Value Share Analysis, By Country 15.10. South America Market Forecast, By Country 15.10.1. Brazil 15.10.2. Colombia 15.10.3. Argentina 15.10.4. Rest of South America 15.11. South America Market Analysis, By Country 15.12. Brazil Market Forecast, By Technology 15.12.1. Radioimmunoassay (RIA) 15.12.2. Enzyme Immunoassay (EIA) 15.12.3. Rapid test 15.12.4. Others 15.13. Brazil Market Forecast, By Product 15.13.1. Reagents & kits 15.13.2. Analyzers/instruments 15.13.3. Software & services 15.14. Brazil Market Forecast, By Application 15.14.1. Therapeutic drug monitoring 15.14.2. Oncology 15.14.3. Cardiology 15.14.4. Endocrinology 15.15. Colombia Market Forecast, By Technology 15.15.1. Radioimmunoassay (RIA) 15.15.2. Enzyme Immunoassay (EIA) 15.15.3. Rapid test 15.15.4. Others 15.16. Colombia Market Forecast, By Product 15.16.1. Reagents & kits 15.16.2. Analyzers/instruments 15.16.3. Software & services 15.17. Colombia Market Forecast, By Application 15.17.1. Therapeutic drug monitoring 15.17.2. Oncology 15.17.3. Cardiology 15.17.4. Endocrinology 15.18. Argentina Market Forecast, By Technology 15.18.1. Radioimmunoassay (RIA) 15.18.2. Enzyme Immunoassay (EIA) 15.18.3. Rapid test 15.18.4. Others 15.19. Argentina Market Forecast, By Product 15.19.1. Reagents & kits 15.19.2. Analyzers/instruments 15.19.3. Software & services 15.20. Argentina Market Forecast, By Application 15.20.1. Therapeutic drug monitoring 15.20.2. Oncology 15.20.3. Cardiology 15.20.4. Endocrinology 15.21. Rest of South America Market Forecast, By Technology 15.21.1. Radioimmunoassay (RIA) 15.21.2. Enzyme Immunoassay (EIA) 15.21.3. Rapid test 15.21.4. Others 15.22. Rest of South America Market Forecast, By Product 15.22.1. Reagents & kits 15.22.2. Analyzers/instruments 15.22.3. Software & services 15.23. Rest of South America Market Forecast, By Application 15.23.1. Therapeutic drug monitoring 15.23.2. Oncology 15.23.3. Cardiology 15.23.4. Endocrinology 15.24. South America Market Attractiveness Analysis 15.24.1. By Technology 15.24.2. By Product 15.24.3. By Application 15.25. PEST Analysis 15.26. Key Trends 15.27. Key Developments 16. Company Profiles 16.1. Market Share Analysis, By Company 16.2. Competition Matrix 16.2.1. Competitive Benchmarking of key players By price, presence, market share, Product, and R&D investment 16.2.2. New Product Launches and Product Enhancements 16.2.3. Market Consolidation 16.2.3.1. M&A By Regions, Investment and Product 16.2.3.2. M&A Key Players, Forward Integration and Backward Integration 16.3. Company Profiles: Key Players 16.3.1. Siemens Healthineers 16.3.1.1. Company Overview 16.3.1.2. Financial Overview 16.3.1.3. Product Portfolio 16.3.1.4. Business Strategy 16.3.1.5. Recent Developments 16.3.1.6. Development Footprint 16.3.2. Becton 16.3.3. Dickinson & Company 16.3.4. BioMérieux 16.3.5. Abbott laboratories 16.3.6. Roche Diagnostics 16.3.7. Danaher Corporation 16.3.8. Ortho Clinical Diagnostics 16.3.9. Sysmex Corporation 16.3.10. Thermo Fisher Scientific, Inc. 16.3.11. Quidel Corporation 16.3.12. Agilent Technologies 16.3.13. PerkinElmer 16.3.14. Mindray 16.3.15. DiaSorin 16.3.16. Others